HF
BEAM icon

HRT Financial’s Beam Therapeutics BEAM Stock Holding History

HRT Financial’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.23M Buy
219,426
+68,243
+45% +$1.89M 0.01% 973
2025
Q4 		$4.19M Sell
151,183
-11,528
-7% -$294K 0.01% 865
2025
Q3 		$3.95M Buy
+162,711
New +$3.24M 0.01% 791
2025
Q1 		– Sell
-26,177
Closed -$649K – 2537
2024
Q4 		$649K Buy
+26,177
New +$668K ﹤0.01% 1312
2024
Q2 		– Sell
-37,955
Closed -$1.25M – 2224
2024
Q1 		$1.25M Buy
37,955
+27,974
+280% +$872K 0.01% 779
2023
Q4 		$271K Buy
+9,981
New +$248K ﹤0.01% 1658
2022
Q2 		– Sell
-20,846
Closed -$1.19M – 2938
2022
Q1 		$1.19M Buy
+20,846
New +$1.37M 0.01% 911
2021
Q3 		– Sell
-1,827
Closed -$235K – 3280
2021
Q2 		$235K Sell
1,827
-6,394
-78% -$509K ﹤0.01% 2299
2021
Q1 		$658K Buy
+8,221
New +$782K 0.01% 1566

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

HRT Financial's BEAM Position: Q1 2026 in Review

HRT Financial increased its Beam Therapeutics (BEAM) stake by 45% in Q1 2026, buying an estimated $1.89M and bringing the position to 219,426 shares worth $5.23M. The position accounts for 0.01% of the portfolio, ranked #973.

HRT Financial first reported a position in BEAM in Q1 2021 and has held it in 9 quarters since. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • HRT Financial held 219,426 shares of Beam Therapeutics worth $5.23M as of Q1 2026.
  • HRT Financial bought 68,243 Beam Therapeutics shares in Q1 2026, an estimated $1.89M.
  • Beam Therapeutics made up 0.01% of HRT Financial's portfolio in Q1 2026, its #973 holding.
  • HRT Financial first reported a position in Beam Therapeutics in Q1 2021 and has held it in 9 quarters since.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.